David Dodds
President at Sucampo Pharma Europe Ltd.
Profile
David Dodds has been Commercial Director of Sucampo Pharma Europe Ltd.
since August 7, 2008.
Mr. Dodds had been Senior International Marketing Manager for Pharmion Ltd since July 2005.
Prior to Pharmion, he held various sales and marketing positions, with Mitsubishi Pharma Europe Ltd., Yamanouchi Pharmaceuticals Europe BV, SmithKline Beecham, Eli Lilly and ICI Pharmaceuticals.
Mr. Dodds has experience in developing and managing business development activities with prospective in-licensees and partners.
He received his Executive MBA from The Open Business School and an Honours degree in Pharmacy from the University of Sunderland School of Pharmacy.
David Dodds active positions
| Companies | Position | Start |
|---|---|---|
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | President | 14/09/2009 |
Training of David Dodds
| University of Sunderland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
- Stock Market
- Insiders
- David Dodds
